ABSTRACT
Introduction
One of the most frequent procedures in oral and maxillofacial surgery offices is the extraction of impacted third molars. It often involves soft tissue flaps and removal of bone tissue; thus, the postoperative inflammation is sometimes accompanied by severe pain, edema, and limited mouth opening. The wide range of complications goes from small normal consequences of postoperative pain and swelling, to persistent nerve damage, mandibular fractures, and severe infections. Minor complications are those whose recovery does not take any particular treatment. Molar extraction causes moderate to severe pain, which are challenges in pain management. [1] [2] Pain is a complex phenomenon, which concerns both nerve mechanisms and psychological perceptions.
It is generally classified as acute pain in which normal pain pathways are triggered and chronic pain in which persists for longer than three months. Chronic pain might also have caused by nerve damage, which is known as neuropathic pain, or by an underlying disease such as cancer. [3] Acute pain is often associated with physical signs originating from the sympathetic branch of the autonomic nervous system, which manifest as tachycardia, hypertension, sweating, mydriasis, and pallor. [1] Therefore, it seems that the symptoms result-ing from surgical trauma after removal of the third molars are an excellent clinical model for studying acute pain. [2, 4] Among the most important parts of postsurgical care is finding an efficient way for pain management.
Pre-emptive analgesia is described as a treatment that is introduced before the surgical procedure to prevent neurophysiological and biochemical consequences of an injury to CNS, which is triggered by a procedure like surgery. [5] [6] The notion of pre-emptive analgesia is to prevent CNS alterations, which consequently lead to pain amplification after initial pain experience. [6] [7] Regarding this protective effect on the nociceptive pathways, pre-emptive analgesia might hypothetically be more helpful than a similar analgesic treatment started after surgery and analgesia prescribed before an initial injurious stimulus may be more effective than the same dose given later. [8] [9] [10] Accordingly, this might reduce the immediate post-surgical pain and preclude the development of subsequent chronic pain. [6, 11] Antiepileptic drugs have been administered for the treatment of neuropathic pain since lamotrigine was initially introduced for treatment trigeminal neuralgia in the 1960s. [12] Other antiepileptic medications have been surveyed, with acceptable efficacy for gabapentin [13] and pregabalin, [14] and these two are now commonly administered. Being used to treat different types of epilepsy, lamotrigine has also been proposed for treatment of chronic neuropathic pain and fibromyalgia in adults in many studies. [12] Lamotrigine is a medication from phenyltriazine group and is chemically dissimilar to other antiepileptic medications. The drug is presented as standard oral tablets (25 to 200 mg) and chewable, dispersible tablets (2 to 25mg), and a new extended release tablet is available in some parts of the world. [12] Lamotrigine is a new generation antiepileptic medication employing its anticonvulsant effect by influencing the sodium channels. It is reported that the medications, which block sodium channels, could be helpful in the treatment of neuropathic pain. [15] [16] An animal model study has reported the efficacy of lamotrigine use in neuropathic pain and showed its effect in experimental pain models such as cold induced pain in humans. [15, [17] [18] The role of lamotrigine as a pre-emptive analgesic to reducepostsurgical pain has also been reported. [16, 19] Observations indicate that increased activity of sodium channels is seemingly the basis for hyperalgesia, like the positive effect of sodium channel inhibitors (e.g. lidocaine) on increasing the pain threshold. [8, 16, 20] Lamotrigine inhibits the function of neuronal sodium channels in a concentration and voltage-dependent manner, decreasing the release of excitatory neurotransmitters, especially glutamate and aspartate. [12, 18, [21] [22] [23] However, up to now, the exact principles responsible for the lamotrigine-induced anticonvulsive effect remain obscure, and probably other targets might control and regulate such effect. [18] The frequent plausible side effects of lamotrigine are dizziness, tremors, sleepiness, loss of coordination, headache, double vision, blurred vision, nausea, vomiting, stomach pain, dry mouth, changes in menstrual periods, back pain, sore throat, runny nose, or sleeping problems (insomnia), however, the reported incidence is low and clinically insignificant. [12, 16, 18, 24] According to the findings of uncontrolled clinical trials with small sample sizes, lamotrigine positively helped pain management in healthy volunteers or those suffering from different neuropathic syndromes. [20] On the other side, there are investigations reporting either a lack of benefit or an inconsistent benefit. [12, [25] [26] [27] Trying to find out about the efficacy of lamotrigine in neuropathy, a systematic review of the available placebo-controlled studies declared that, so far, there are no evidences to confirm that lamotrigine can be effective in treatment of chronic pain. [12] However, in this systematic review, no clinical trials on acute pain have been considered and they reported there was little or no use or intended use of lamotrigine and similar medications in acute pain, or other forms of chronic pain. [12] It is believed that surgical procedures, even skin incisions, may result in initial sensitization .On the other hand, the observations on the genesis and perception of pain brought about the notion that analgesia administered before an initial noxious stimulus may be more effective than the same dose given later. [9] [10] Moreover, the literature review shows that the effect of lamotrigine on acute post-surgical pain of third molar extraction has not been studied, hence, the current study decided to assess the effect of pre-emptive administra- The sample size was determined based on a power test (available on http://www.lee.dante.br/pesquisa/ amostragem/amostra.html) proposing a sample size of nine patients per group to achieve a power of 0.8. [2] The remaining 100 patients were divided into two groups (n=50). The experimental group received lamotrigine, and the control group received placebo in the preoperative setting one hour before the surgery.
The side to undergo extraction first and the drug to be Throughout the surgery, the heart rate, blood pressure, and blood oxygen saturation were recorded at specified intervals. By the end of the operation, the analgesics usage according to the patients' self-assessment of pain in the VAS was also registered. The obtained data were statistically analyzed by using SPSS software. Chi-square, Fisher's exact test, and Mann-Whitney U test were employed as appropriated. Significance level was set at p< 0.05.
Results
This study was first concerned with the pain intensity over the first 12 postoperative hours, and second with the efficacy, measures included analgesic consumption as well as the safety and tolerability of lamotrigine. One hundred eligible patients completed the study in form of two random intervention groups. Figure 1 illustrates the flowchart of the trail.
The mean age of the studied patients was 25.9±7.5
years, the oldest being 55, and the youngest 14. Regarding the sex, 46% of patients were male and 54% were female, although the study was not looking for sexbased findings. Table 1 shows the demographic characteristics of patients in the two studied groups. Other clinical characteristics including type of impacted tooth, length of operation, duration of anesthesia, surgery duration, and analgesic use are displayed in Table 2 . There has also been discussion on the efficacy of lamotrigine as a pre-emptive analgesic to reduce postsurgical pain. [19] Moreover, the intensity of acute postoperative pain was reported to be associated with the development of chronic pain. More recently, it has been shown that neuronal alpha-4-beta2-nicotinic acetylcholine receptors may be a target for lamotrigine, which may regulate its antiepileptic effects. [12, 16, 18, 24] McCleane et al. [16] reported that treatment of neuropathic pains could benefit from agents that block sodium channels. Likewise, Bonicalzi et al. [19] discussed the effect of lamotrigine as a preemptive analgesic on decreasing the postoperative pain. Systematic reviews performed by Wiffen et al. [12, 16, 24] reported that Bonicalzi et al. introduced the use of lamotrigine for acute pain, however, in their study all patients were given buprenorphine, a potent analgesic. [19] Seven other research studied the central post stroke pain, diabetic neuropathy, HIV related neuropathy, intractable neuropathic pain, [26] spinal cord injury related pain and trigeminal neuralgia. [37] In the study of McCleane, [26] the use of lamotrigine 200 mg in patients with symptoms of shooting/lancinating pain, burning, numbness, allodynia and paraesthesia/dysesthesia were examined but no useful analgesic benefit could be achieved. Although a reduction in the overall pain score of 1 mm was reported, but it was not statistically significant.
In a placebo-controlled trial, Zakrzewska et al. [37] noted that lamotrigine helped the treatment of refractory trigeminal neuralgia.Fourteen participants recruited in their crossover study comparing lamotrigine with placebo in two two-week phases with a three-day long washout. Lamotrigine showed to be slightly more effective than placebo in this study with limited cases and statistical analysis achieved a hardly significant power. [12] As mentioned earlier, lamotrigine has been studied in the past for management of painful neuropathic conditions with only few establishing their efficacy in trigeminal neuralgia. In addition, this drug has negligible effects on hematological and biochemical indices; [38] does not induce hepatic enzyme, has very slight drug interactions and protein binding which makes them proper for use in older patients. [38] Likewise, in comparison to other drugs, this medication requires only twice daily prescription, which consequently increases the patient's compliance. The adverse-effect reported this medication has also been recognized to be acceptable. [38] The systematic reviews show that there are not consistently regarding the adverse effects of lamotrigine. [12, 16] They stated that the incidence of mild and severe adverse effects could not be possibly determined.
Lamotrigine can produce rash with the incidence of approximately 7%. Severe possible life-threatening rashes such as Stevens Johnson Syndrome are appraised to occur at an incidence of one in 1000. [12] Other significant symptoms included drowsiness, headache, and insomnia, which were not more than the control group. [12] The present investigation was focused on the effi- Leach et al. [23] by decreasing the severity of postoperative pain, lamotrigine might also decrease the upcoming adverse events.
Although some uncontrolled clinical trials with small sample sizes claimed lamotrigine to be helpful in treating pain in normal individuals or those with neuropathic syndromes, there are reports on lack of benefit or inconsistent benefit to this agent. [26] [27] 39] Aiming to investigate the advantages of lamotrigine in neuropathic pains, consequent systematic reviews of all the placebo-controlled found no evidence to confirm the efficacy of lamotrigine as a therapy for pain syndromes up to date of their study. [12, 16, 24] The results of the current study indicated that the difference between study and control group was not statistically significant considering the severity of acute postoperative pain which confirms and adds to the results yielded by Wiffen et al. [12] that lamotrigine does not have a significant place in therapy based on available evidence.
Nevertheless, more studies with larger samples of study and more sophisticated pain assessments need to be conducted to oppose or strengthen the findings of our study.
Conclusion
Within the limitations of a small sample size and the subjective nature of the assessments, the current results revealed that lamotrigine was not effective more than placebo in controlling the postoperative pain of third molar surgery.
